Ibutilida [INN-Spanish] en es it fr

Ibutilida [INN-Spanish] Brand names, Ibutilida [INN-Spanish] Analogs

Ibutilida [INN-Spanish] Brand Names Mixture

  • No information avaliable

Ibutilida [INN-Spanish] Chemical_Formula


Ibutilida [INN-Spanish] RX_link


Ibutilida [INN-Spanish] fda sheet

Ibutilida_[INN-Spanish] FDA

Ibutilida [INN-Spanish] msds (material safety sheet)

Ibutilida [INN-Spanish] Synthesis Reference

No information avaliable

Ibutilida [INN-Spanish] Molecular Weight

384.578 g/mol

Ibutilida [INN-Spanish] Melting Point

No information avaliable

Ibutilida [INN-Spanish] H2O Solubility

100 mg/mL

Ibutilida [INN-Spanish] State


Ibutilida [INN-Spanish] LogP


Ibutilida [INN-Spanish] Dosage Forms

Solution (for injection); Suspension

Ibutilida [INN-Spanish] Indication

Indicated for the rapid conversion of atrial fibrillation or atrial flutter of recent onset to sinus rhythm.

Ibutilida [INN-Spanish] Pharmacology

Ibutilide fumurate prolongs the action potential duration and increases both atrial and ventricular refractoriness in vivo, i.e., class III electrophysiologic effects. Voltage clamp studies indicate that Ibutilide, at nanomolar concentrations, delays repolarization by activation of a slow, inward current (predominantly sodium), rather than by blocking outward potassium currents, which is the mechanism by which most other class III antiarrhythmics act.

Ibutilida [INN-Spanish] Absorption

Rapid after intravenous injection

Ibutilida [INN-Spanish] side effects and Toxicity

No information avaliable

Ibutilida [INN-Spanish] Patient Information

No information avaliable

Ibutilida [INN-Spanish] Organisms Affected

Humans and other mammals